Evidence map›Paper›PMID 37208774›Full record

ArticleCancer imaging : the official publication of the International Cancer Imaging Society2023

Correction to: Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy.

Therese Sjöholm, Alexander Korenyushkin, Gustav Gammelgård, Tina Sarén, Tanja Lövgren, Angelica Loskog, Magnus Essand, Joel Kullberg, Gunilla Enblad, Håkan Ahlström

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Therese Sjöholm *Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. therese.sjoholm@surgsci.uu.se.
Alexander Korenyushkin *Antaros Medical AB, Mölndal, Sweden.
Gustav GammelgårdDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Tina SarénDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Tanja LövgrenDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Angelica LoskogDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Magnus EssandDepartment of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Joel KullbergDepartment of Surgical Sciences, Uppsala University, Uppsala, Sweden.
Gunilla Enblad *Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.
Håkan Ahlström *Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37208774
PMCPMC10197829

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.